BIOMAT Database Logo BIOMAT Database Logo

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand. 2015

Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

UI MeSH Term Description Entries
D008554 Melioidosis A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, PNEUMONIA and BACTEREMIA. Whitmore's Disease,Burkholderia pseudomallei Infection,Burkholderia pseudomallei Infections,Disease, Whitmore's,Infection, Burkholderia pseudomallei,Melioidoses,Whitmore Disease
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam
D015662 Trimethoprim, Sulfamethoxazole Drug Combination A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. Trimethoprim-Sulfamethoxazole Combination,Abactrim,Bactifor,Bactrim,Biseptol,Biseptol-480,Centran,Centrin,Co-Trimoxazole,Cotrimoxazole,Drylin,Eslectin,Eusaprim,Insozalin,Kepinol,Kepinol Forte,Lescot,Metomide,Oriprim,Septra,Septrin,Sulfamethoxazole-Trimethoprim Combination,Sulprim,Sumetrolim,TMP SMX,TMP-SMX,Trimedin,Trimethoprim-Sulfamethoxazole,Trimethoprimsulfa,Trimezole,Trimosulfa,Biseptol 480,Biseptol480,Co Trimoxazole,Sulfamethoxazole Trimethoprim Combination,Trimethoprim Sulfamethoxazole,Trimethoprim Sulfamethoxazole Combination
D016957 Burkholderia pseudomallei A species of gram-negative, aerobic bacteria that causes MELIOIDOSIS. It has been isolated from soil and water in tropical regions, particularly Southeast Asia. Pseudomonas pseudomallei
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
June 2005, The Journal of antimicrobial chemotherapy,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
October 2014, International journal of antimicrobial agents,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.
February 2021, PLoS neglected tropical diseases,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Ribotyping of Burkholderia pseudomallei from clinical and soil isolates in Thailand.
December 2001, Acta tropica,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
January 2012, PloS one,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand.
September 2009, PLoS neglected tropical diseases,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.
September 2013, Antimicrobial agents and chemotherapy,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Molecular characterization of clinical Burkholderia pseudomallei isolates from India.
July 2011, The American journal of tropical medicine and hygiene,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.
October 1999, Journal of general internal medicine,
Natnaree Saiprom, and Premjit Amornchai, and Vanaporn Wuthiekanun, and Nicholas P J Day, and Direk Limmathurotsakul, and Sharon J Peacock, and Narisara Chantratita
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
September 2017, Journal of global antimicrobial resistance,
Copied contents to your clipboard!